Regenosca, a Lausanne based startup developing non-invasive regenerative tissue implants, has closed a CHF 1M pre-seed round from private investors, Business Angels Switzerland and Venture Kick. The funds will be used to demonstrate endoscopic delivery of TissueSpan implants.
